inovio pharmaceuticals inc
(INO:Consolidated Issue Listed on NASDAQ Global Select )
J. Joseph Kim Ph.D.
Chief Executive Officer, President, Director and Member of Finance Committee, Inovio Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 11 board members in 3 different organizations across 4 different industries.|
See Board Relationships
As of Fiscal Year 2014
Dr. J. Joseph Kim, Ph.D has been the Chief Executive Officer of Inovio Pharmaceuticals, Inc. (alternate name: Inovio Biomedical Corp) since June 1, 2009 and has been its President since October 6, 2009. Dr. Kim co-founded ADViSYS Inc., a subsidiary of Viral Genomix in 1997 and serves as its Chief Executive Officer and President. He co-founded VGX Pharmaceuticals, LLC (Formerly Viral Genomix, Inc) in 2000 and served as its Chief Executive Officer and President from 2000 ...
660 West Germantown PikePhone: 267-440-4200
Plymouth Meeting, Pennsylvania 19462
Board Members Memberships*
Co-Founder, Chief Executive Officer, President and Director
Chief Executive Officer, President, Director and Member of Finance Committee
Massachusetts Institute of Technology
The University of Pennsylvania
University of Pennsylvania - The Wharton School
|Douglas J. Swirsky CPA, CFA||Chief Executive Officer, President, Corporate Secretary and Director|
|Vijay B. Samant||Chief Executive Officer, President, Acting Chief Financial Officer and Director|
|Eddie Gray||Chief Executive Officer and Director|
Dynavax Technologies Corporation
|Daniel J. O'Connor Esq.||Chief Executive Officer, President and Director|
|William D. Clark||Chief Executive Officer, President and Director|
Genocea Biosciences, Inc.
|$393.6K||Compensation as of Fiscal Year 2014.|